CognICA

News

The FDA has approved an artificial intelligence-based test for early detection of dementia that can be carried out on an iPad in five minutes.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.